Joerg Mayer

Prof. Dr. Joerg Mayer

SAMS, University of Georgia, Athens, Alabama, USA
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Veterinary Clinics of North America: Exotic Animal Practice
Verified
Journal Article
Closed access
LKLeonie Kondert
Leonie Kondert
JMJoerg Mayer
Joerg Mayer

1 September 2011 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Closed access
JMJoerg Mayer
Joerg Mayer
ASAmy Sato
Amy Sato
MKMatti Kiupel
Matti Kiupel
JDJulie DeCubellis
Julie DeCubellis
TDThomas Donnelly
Thomas Donnelly
Case Description—A 0.65-kg (1.43-lb) 24-month-old sexually intact male albino pet rat was examined because of a 3-week history of hypodipsia, apparent blindness, and sudden change in behavior. Clinical Findings—The rat was able to move around its cage but appeared unaware of its surroundings, was visually unresponsive, and seemed unusually aggressive. The rat's hind limbs appeared mildly paretic, and it had sporadic difficulty placing its hind limbs on a flat surface. Given the rat's age, history, and physical examination findings, the primary differential diagnosis was a pituitary tumor. Magnetic resonance imaging (MRI) of the rat's brain was performed and revealed a large pituitary mass, which was indicative of a tumor. Treatment and Outcome—Cabergoline (0.6 mg/kg [0.27 mg/lb], PO, q 72 h) was administered. On follow-up MRI 2 months later, the pituitary mass had substantially decreased in size. For 6 months following the second MRI study, the rat continued to receive the same dosage of cabergoline and had no clinical signs of disease or unusual behavior. However, at 8.5 months after the start of the treatment, the rat was in poor condition and had clinical signs similar to those initially. A third MRI study was performed and revealed substantial regrowth of the mass. The rat was euthanized and a necropsy was performed; a histopathologic diagnosis of pituitary adenoma was made. Clinical Relevance—Pituitary adenomas have long been recognized as a common finding in geriatric rats (> 18 months old). Affected rats may respond favorably to oral administration of cabergoline.

1 January 2013 in Journal of Exotic Pet Medicine
Verified
Journal Article
Open access
PDF file
JMJoerg Mayer
Joerg Mayer
PHPatrick Hensel
Patrick Hensel
JMJohanna Mejia-Fava
Johanna Mejia-Fava
JBJoão Brandão
João Brandão
SDStephen Divers
Stephen Divers
Fish lice can cause significant morbidity and death in heavily infested fish. In addition to being a mechanical irritant when sucking blood, Argulus sp have been shown to be the vector for other fish diseases. Koi carp from a pond environment were presented with multiple raised dark spots on their dorsa and sides. The primary differential disease diagnosis was an Argulus sp. Parasites removed from the affected fish were examined under a dissection microscope, and the definitive diagnosis was determined to be Argulus sp infestation. Treatment with lufenuron (Program; Novartis, Greensboro, NC USA) was initiated with one 409.8-mg tablet per 1,000 US gallons (3,785 L) of water for a concentration of approximately 0.1 mg/L. This treatment was repeated once per week for 5 weeks. The fish have been monitored for 13 months after the initial treatment, and thus far, there has been no reappearance of Argulus sp within the aquatic environment.Published by Elsevier Inc.

15 May 2009 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Open access
CSCara R. Sweet
Cara R. Sweet
ELEric Linnetz
Eric Linnetz
EGEthan Golden
Ethan Golden
JMJoerg Mayer
Joerg Mayer

1 February 2013 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Closed access
JMJoerg Mayer
Joerg Mayer
RWRobert Wagner
Robert Wagner
MMMark A. Mitchell
Mark A. Mitchell
KFKellie Fecteau
Kellie Fecteau
Objective—To evaluate the effects of administration of recombinant human (rh) thyroid-stimulating hormone (TSH) for evaluation of thyroid function in euthyroid guinea pigs (Cavia porcellus). Design—Prospective, experimental study. Animals—10 healthy, sexually intact, pet guinea pigs (approx 1 year of age). Procedures—Guinea pigs were given rhTSH (100 μg, IM); plasma thyroxine concentrations were determined prior to and 3 and 4 hours after rhTSH injection. The animals were housed in 2 groups on the basis of sex and fed different commercial maintenance diets according to their husbandry. Results—There was no significant difference in thyroxine concentrations between males and females before or after rhTSH injection. There was also no difference between thyroxine concentrations at 3 versus 4 hours after rhTSH injection. There was a significant difference between thyroxine concentrations before (median, 9.05 nmol/L [0.70 μg/dL]; 10% to 90% range, 7.39 to 16.99 nmol/L [0.57 to 1.32 μg/dL]) and after (mean ± SD, 23.95 ± 4.2 nmol/L) rhTSH injection. Euthyroid guinea pigs had plasma thyroxine concentrations of at least 7.30 nmol/L (0.57 μg/dL) and an increase of at least 2.6 times prestimulation thyroxine concentrations at 3 or 4 hours after stimulation. Conclusions and Clinical Relevance—The results suggested that rhTSH administered IM can be used for the TSH stimulation testing in guinea pigs. We suggest thyroxine concentration in a euthyroid guinea pig should at least double 3 to 4 hours after rhTSH injection.

1 April 2017 in Journal of Exotic Pet Medicine
Verified
Journal Article
Closed access
PDF file
JMJoerg Mayer
Joerg Mayer
SBSusan Brown
Susan Brown
MMMark A. Mitchell
Mark A. Mitchell